Get started
Author

Cho-Chung Ys

Observed names: Y ChoChung, Y S Cho-Chung, Y. S. CHO‐CHUNG, YS CHOCHUNG, YS Cho-Chung
OpenAlex ID: A5110040577
Clinical Studies in Patients with Solid Tumors using a Second‐Generation Antisense Oligonucleotide (GEM®231) Targeted against Protein Kinase A Type I
2003 · S. MANI, S. GOEL, et al. · Annals of the New York Academy of Sciences · 31
On the mechanism of cyclic AMP-mediated growth arrest of solid tumors.
1980 · Y S Cho-Chung · PubMed · 17
Differentiation Therapy of Cancer Targeting the Ri-alpha Regulatory Subunit of Camp-dependent Protein-kinase (review)
1993 · YS CHOCHUNG · International Journal of Oncology · 10
Multidrug resistance in cancer (review)
1996 · R Srivastava, A Srivastava, et al. · International Journal of Oncology · 8
Overexpression of RII beta regulatory subunit of protein kinase A induces growth inhibition and reverse-transformation in SK-N-SH human neuroblastoma cells
1996 · S Kim, G Lee, et al. · International Journal of Oncology · 8
129. Role of type I regulatory subunit (RI) of cAMP dependent protein kinase (PKA) in multidrug resistance (mdr) of cancer cells
1992 · YS Cho-Chung, A Budillon, et al. · Biomedicine & Pharmacotherapy · 5
Antisense DNA toward type I protein kinase A produces sustained inhibition of tumor growth.
1997 · Y S Cho-Chung · PubMed · 3
Chemical modification enhances the inhibitory effect of regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase type I on cell proliferation.
1991 · Y S Cho-Chung, M V Nesterova, et al. · PubMed · 3
Novel growth inhibitory effect of 8-Cl-cAMP is dependent on serum factors that modulate protein kinase A expression but not the hydrolysis of 8-Cl-cAMP
1996 · A Budillon, T Clair, et al. · International Journal of Oncology · 1
Nucleic acid therapeutics--millennium conference. 8-11 January 2000, Clearwater Beach, FL, USA.
2000 · Y S Cho-Chung · PubMed
149. 8-CI-cAMP acts synergistically with tumor necrosis factor (TNFα), TGFβ, or retinoic acid (RA) in growth inhibition and differentiation of human leukemia and lymphoma cells
1992 · A Budillon, T Clair, et al. · Biomedicine & Pharmacotherapy
165. Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia (AML) patients by site-selective 8-chloro-cyclic adenosine 3′, 5′ monophasphate (8-CI-cAMP): a new approach for differentiation therapy of AML in humans
1992 · A Pinto, D Aldinucci, et al. · Biomedicine & Pharmacotherapy
Works count: 12
Citation count: 86
H-index: 5
I10-index: 3
Year
Topic
Type